Uganda has achieved large gains against malaria through improving intervention delivery. At the same time, this year’s outbreak in northern Uganda highlights a need for stronger, more focal monitoring of malaria needs. No magic bullet exists against malaria, nor will a one-size-fits-all solution work to end the disease. But by harnessing local evidence and devising multipronged, targeted programs, Uganda aims to accelerate toward its goal of reaching zero malaria.
Global Burden of Disease Health Financing Collaborator Network. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050. The Lancet. 24 April 2019. doi: http://dx.doi.org/10.1016/S0140-6736(19)30841-4
Global Burden of Disease Health Financing Collaborator Network. Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40. The Lancet. 17 Apr 2018.
Global Burden of Disease Health Financing Collaborator Network. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015. The Lancet. 17 Apr 2018.
Wollum A, Dansereau E, Fullman N, Achan J, Bannon KA, Burstein R, Conner RO, DeCenso B, Gasasira A, Haakenstad A, Hanlon M, Ikilezi G, Kisia C, Levine AJ, Masters SH, Njuguna P, Okiro EA, Odeny TA, Roberts DA, Gakidou E, Duber HC. The effect of facility-based antiretroviral therapy programs on outpatient services in Kenya and Uganda. BMC Health Services Research. 2017 Aug 16. doi: 10.1186/s12913-017-2512-9.
Carlson S, Duber HC, Achan J, Ikilezi G, Mokdad AH, Stergachis A, Wollum A, Bukhman G, Roth GA. Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa. Heart. 2017 May 10. doi: 10.1136/heartjnl-2016-310913.
Di Giorgio L, Moses MW, Fullman N, Wollum A, Conner RO, Achan J, Achoki T, Bannon KA, Burstein R, Dansereau E, DeCenso B, Delwiche K, Duber HC, Gakidou E, Gasasira A, Haakenstad A, Hanlon M, Ikilezi G, Kisia C, Levine AJ, Maboshe M, Masiye F, Masters SH, Mphuka C, Njuguna P, Odeny TA, Okiro EA, Roberts DA, Murray CJL, Flaxman AD. The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia. BMC Medicine. 2016 20 July. doi: 10.1186/s12916-016-0653-
Duber HC, Roberts DA, Ikilezi G, Fullman N, Gasasira A, Gakidou G, Haakenstad A, Levine AJ, Achan J. Evaluating facility-based antiretroviral therapy program effectiveness: a pilot study comparing viral load suppression and retention rates. Tropical Medicine & Hygiene. 2016 March 21. doi: 10.1111/tmi.12694.
Roberts DA, Ng M, Ikilezi G, Gasasira G, Dwyer-Lindgren L, Fullman N, Nalugwa T, Kamya M, Gakidou E. Benchmarking health system performance across regions in Uganda: a systematic analysis of levels and trends in key maternal and child health interventions and outcomes, 1990–2011. BMC Medicine. 2015 December 3;13(285). doi: 10.1186/s12916-015-0518-x.
Dansereau E, Gakidou E, Ng M, Achan J, Burstein R, DeCenso B, Gasasira A, Ikilezi G, Kisia C, Masters SH, Njuguna P, Odeny TA, Okiro EA, Roberts DA, Duber HC. Trends and determinants of antiretroviral therapy patient monitoring practices in Kenya and Uganda. PLOS One. 2015 Aug 14. doi: 10.1371/journal.pone.0135653.
Duber HC, Dansereau E, Masters SH, Achan J, Burstein R, DeCenso B, Gasasira A, Ikilezi G, Kisia C, Masiye F, Njuguna P, Odeny T, Okiro E, Roberts DA, Gakidou E. Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia. PLOS One. 2015 March 25. doi: 10.1371/journal.pone.0120350.
Masters SH, Burstein R, DeCenso B, Moore K, Haakenstad A, Ikilezi G, Achan J, Osei I, Gashong B, Kisia C, Njuguna P, Babigumira J, Kumar S, Hanlon M, Gakidou E. Pharmaceutical availability across levels of care: evidence from facility surveys in Ghana, Kenya, and Uganda. PLOS ONE. 2014; 9(12): e114762.